Mr. Hylton Karon reports

IFABRIC CORP. ANNOUNCES 1,000 STORE EXPANSION OF DOCTOR'S CHOICE(R) SCRUBS AT U.S. NATIONAL RETAILER

iFabric Corp.'s wholly owned subsidiary, Intelligent Fabric Technologies (North America) Inc. (IFTNA), has secured a 1,000-store expansion of Doctor's Choice scrubs at a leading United States national big-box retailer. This expansion significantly broadens in-store access to Doctor's Choice scrubs following the program's initial rollout, which began on-line and progressed into stores during late 2025.

The company believes this expanded footprint reflects the retailer's confidence in the Doctor's Choice scrubs program and validates both the strong consumer acceptance of the brand and the performance benefits delivered by the IFTNA proprietary textile technologies integrated into the collection.

"An expansion of this magnitude is a tremendous milestone for Doctor's Choice scrubs and for IFTNA," said Giancarlo Beevis, president and chief executive officer of IFTNA. "A move to an additional 1,000 stores is a clear signal that the retailer believes in the product, the brand and -- most importantly -- the differentiated performance story our technologies deliver to health care professionals every day," added Mr. Beevis.

Doctor's Choice technology enhanced scrubs were developed to combine comfort, durability and practical clinical features with IFTNA's performance finishes. The current Doctor's Choice scrub platforms integrate multiple IFTNA technologies, including:

• PROTX2 (advanced antimicrobial) combined with ecoPEL (durable water repellency);
• PROTX2 (advanced antimicrobial) combined with DryTX (moisture management).

PROTX2 and ecoPEL have been supported by IFTNA's recently announced peer-reviewed clinical trial results, which demonstrated statistically significant reductions in surface bacterial contamination on treated scrubs worn in real-world health care environments compared to untreated scrubs.

"Health care professionals have been waiting a long time for medical textiles that don't just claim performance -- but are supported by real clinical evidence," continued Mr. Beevis. "We believe there is pent-up demand across the medical community for apparel that can offer an added layer of protection for professionals and their patients. The rapid expansion of Doctor's Choice scrubs strongly reinforces that demand and the end-user acceptance of this game-changing and clinically validated technology," concluded Giancarlo Beevis.

The Doctor's Choice scrub assortment is available both on-line and through the retailer's expanding store network.

About iFabric Corp.

iFabric develops, licenses and commercializes innovative performance technologies for textiles and apparel. Through its Intelligent Fabric Technologies (North America) division, iFabric partners with global brands and retailers to deliver enhanced fabric functionality -- ranging from antimicrobial technologies to moisture management and PFAS-free water repellency -- across diverse end uses.

About Intelligent Fabric Technologies (North America) Inc.

Intelligent Fabric Technologies (North America), a wholly owned subsidiary of iFabric, engineers and supplies proprietary textile chemistries-including PROTX2, ecoPEL and DryTX -- and provides end-to-end program capabilities spanning technology integration, product development, branding support, and manufacturing execution across consumer, medical and industrial markets.

About PROTX2

PROTX2 is an eco-friendly textile technology designed to provide antimicrobial and anti-odour protection. When applied, PROTX2 is engineered to deliver durable performance intended to last through the life of the garment.

About ecoPEL

ecoPEL is a fluorine-free durable water repellent (DWR) technology designed to help deliver water repellency while maintaining fabric comfort and breathability, and to support sustainability objectives by avoiding fluorinated chemistry.

About DryTX

DryTX is a moisture-management technology designed to help improve comfort through wicking and quick-dry properties.

We seek Safe Harbor.